| Variable, n (%) |
Placebo/Edivoxetine N = 195 |
Edivoxetine/Edivoxetine N = 93 |
All Patients N = 288 |
| Patients with at least one TEAE |
176 (90.3) |
79 (85.9) |
255 (88.9) |
| Nasopharyngitis |
56 (28.7) |
29 (31.5) |
85 (29.6) |
| Tachycardia |
62 (31.8) |
17 (18.5) |
79 (27.5) |
| Hyperhidrosis |
33 (16.9) |
16 (17.4) |
49 (17.1) |
| Palpitations |
36 (18.5) |
12 (13.0) |
48 (16.7) |
| Nausea |
26 (13.3) |
8 (8.7) |
34 (11.9) |
| Heart rate increased |
25 (12.8) |
7 (7.6) |
32 (11.2) |
| Constipation |
19 (9.7) |
7 (7.6) |
26 (9.1) |
| Dizziness |
21 (10.8) |
4 (4.4) |
25 (8.7) |
| Headache |
17 (8.7) |
7 (7.6) |
24 (8.4) |
| Vomiting |
14 (7.2) |
3 (3.3) |
17 (5.9) |